IDS Monthly Survey: April 2019
LAST MONTH’S SURVEY QUESTION:
In last month’s edition of Diabetes Bites we asked what you think about insulin companies charging $250-$300 for a vial of insulin:
A. The high prices are necessary to maintain product quality and further research & development
B. Inflation explains some, but not all, of the price increases
C. It’s time for the government to underwrite part of the cost of insulin so that it is affordable for everyone
D. Insulin is necessary for survival! Pharmaceutical companies need to reduce the cost dramatically.
E. Too late for apologies. Big pharma execs should be rounded up and tried as criminals.
171 People vented their obvious frustration. Here’s what you had to say:
THIS MONTH’S NEW SURVEY QUESTION:
This month, we’d like to know what you think about sharing your CGM (continuous glucose monitor) data with a partner or family member:
A. Of course I share my data with my partner! They have every right to know what’s going on with my diabetes.
B. I share it, but only so that they are alerted and can assist if I’m having a serious high or low blood sugar.
C. I share it, but only because they insist on knowing what’s going on.
D. No way I’m letting my partner anywhere near my CGM data.